Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the opening of Curaleaf Edgewater Park, the Company's second dispensary in New Jersey and 107th dispensary nationwide.
In addition, the Company announced that its second New Jersey cultivation facility, located in Winslow, completed its first harvest and is now fully operational. The new site has tripled Curaleaf's cultivation capabilities to serve both the existing New Jersey medical market and the forthcoming adult-use market.
"We are thrilled to grow alongside New Jersey's flourishing medical community and expand access to best-in-class cannabis products to patients in Edgewater Park," said Joe Bayern, CEO of Curaleaf. "We continue to work closely with state leadership and regulators to create a successful and sustainable adult-use market, and our expansion positions us to meet the market's increasing needs while creating hundreds of new jobs in the state."
Curaleaf Edgewater Park is a 7,640 square foot dispensary conveniently located off the Burlington Pike at 4237 Route 130 South and is open to all patients with a valid medical card. Curaleaf has been serving New Jersey's medical community since the opening of its Bellmawr dispensary in 2015, and the Company anticipates opening a third dispensary in Central New Jersey later this summer.